Waters (WAT) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$4.6B

Revenue (quarter)

$1.6B

Revenue growth (year over year)

+113.36%

Gross profit (trailing twelve months)

$2.4B

Gross margin

50.89%

Net income (trailing twelve months)

$166.6M

Net income (quarter)

−$136.0M

Net income growth (year over year)

−192.52%

Net margin

3.59%

Return on equity

1.92%

EPS (trailing twelve months)

$3.98

Book value per share

$154.70

P/E (trailing twelve months)

263.03

Price to book

2.88

Debt to assets

38.61%

Payout ratio

—

Dividend yield

—

Company profile

Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with Becton Dickinson's life science and diagnostics business, which increased its concentration in diagnostics and discovery-related life science tools.

• Is Waters (WAT) profitable?

  Yes. Waters earned $166.6M in net income over the trailing twelve months, a net margin of 3.59%.

• How much revenue does Waters (WAT) make?

  Waters generated $4.6B in revenue over the trailing twelve months, up 113.36% year over year.

• What is WAT's P/E ratio?

  Waters trades at 263.0 times trailing twelve-month earnings, on an EPS of $3.98.

• How do I buy stock in Waters (WAT)?

  WAT trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.